(19)
(11) EP 4 117 712 A1

(12)

(43) Date of publication:
18.01.2023 Bulletin 2023/03

(21) Application number: 21717209.7

(22) Date of filing: 09.03.2021
(51) International Patent Classification (IPC): 
A61K 38/40(2006.01)
A61K 9/00(2006.01)
A61P 31/12(2006.01)
A61K 31/198(2006.01)
A61M 15/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/40; A61P 31/12; A61K 31/198; A61K 31/728; A61K 9/0075; A61K 47/26; A61K 47/36; A61M 11/003; A61M 15/0028; A61M 2202/064
 
C-Sets:
  1. A61K 38/40, A61K 2300/00;
  2. A61K 31/198, A61K 2300/00;
  3. A61K 31/728, A61K 2300/00;
  4. A61M 2202/064, A61M 2202/0007;

(86) International application number:
PCT/IB2021/051941
(87) International publication number:
WO 2021/181261 (16.09.2021 Gazette 2021/37)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.03.2020 IT 202000005026

(71) Applicant: SOFAR S.p.A.
20060 Trezzano Rosa (MI) (IT)

(72) Inventors:
  • BIFFI, Andrea
    20060 Trezzano Rosa [MI] (IT)
  • FIORE, Walter
    20060 Trezzano Rosa [MI] (IT)

(74) Representative: Benedetto, Marco 
Marben S.r.l. Via Larga, 16
20122 Milano
20122 Milano (IT)

   


(54) LACTOFERRIN FOR ORAL INHALATION USE FOR THE TREATMENT OF A DISEASE CAUSED BY A SARS-CORONA VIRUS